NASDAQ · UFPT
Healthcare · Medical - Devices
$293.30
Down-$1.40 (-0.48%)
Updated Oct 30, 2026, 1:46 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · UFPT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
UFPT closed at $293.30 after 21 trading sessions, down 0.57% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $288.74 | $295.48 | $286.00 | $293.30 | 107.5K |
| Oct 28, 2026 | $291.13 | $295.25 | $283.20 | $286.00 | 71.13K |
| Oct 27, 2026 | $292.55 | $295.43 | $283.68 | $294.84 | 73.29K |
| Oct 26, 2026 | $298.48 | $298.48 | $291.07 | $291.28 | 82.22K |
| Oct 23, 2026 | $295.00 | $296.91 | $289.09 | $295.78 | 112.19K |
| Oct 22, 2026 | $288.18 | $297.72 | $288.18 | $297.33 | 83.85K |
| Oct 21, 2026 | $292.87 | $294.835 | $287.71 | $290.11 | 94.96K |
| Oct 20, 2026 | $295.02 | $298.21 | $289.57 | $291.34 | 131.01K |
| Oct 19, 2026 | $291.65 | $295.545 | $289.025 | $293.25 | 98.15K |
| Oct 16, 2026 | $297.19 | $299.86 | $288.94 | $291.67 | 82.21K |
| Oct 15, 2026 | $291.11 | $301.13 | $291.11 | $297.19 | 100.52K |
| Oct 14, 2026 | $291.72 | $297.675 | $287.24 | $291.10 | 152.91K |
| Oct 13, 2026 | $297.80 | $298.50 | $291.26 | $294.29 | 100.83K |
| Oct 12, 2026 | $286.49 | $296.69 | $285.58 | $295.82 | 99.54K |
| Oct 9, 2026 | $285.78 | $291.30 | $283.22 | $288.97 | 92.65K |
| Oct 8, 2026 | $291.50 | $292.715 | $286.135 | $286.56 | 105.73K |
| Oct 7, 2026 | $297.06 | $303.62 | $291.225 | $292.87 | 114.11K |
| Oct 6, 2026 | $310.15 | $310.15 | $300.3165 | $302.87 | 132.59K |
| Oct 5, 2026 | $300.70 | $308.98 | $300.03 | $307.33 | 134.95K |
| Oct 2, 2026 | $299.99 | $303.43 | $295.33 | $300.70 | 117.15K |
| Oct 1, 2026 | $296.44 | $298.6528 | $294.5508 | $294.99 | 103.91K |
The latest Smart Investors Daily articles mentioning UFPT.
Company
Market Activity
Research & News
UFPT research
Company profile and research snapshot.
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2025 | Lake Street | Buy | — |
| Mar 28, 2025 | Raymond James | Market Perform | — |
| Jul 17, 2024 | Lake Street | Buy | — |
| Jul 2, 2024 | Lake Street | Buy | — |
| Jun 28, 2024 | Lake Street | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 6, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how drug development inputs & services stocks fared in Q2, starting with UFP Technologies (NASDAQ:UFPT).
SeekingAlpha · Feb 25, 2026
ChartMill · Feb 24, 2026
UFP Technologies reports record 2025 results despite Q4 revenue miss, beating EPS estimates. Stock dips on mixed earnings.
Benzinga · Feb 24, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning UFPT.
